Autor: "Pino LE" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Preliminary investigations on the sequence heterogeneity of the 18S rRNA gene of Theileria equi and Babesia caballi strains collected from a horse population in Central Italy
Autorzy:: Cersini, A.
Del Pino, LE Bartolomé
Antognetti, V.
Lorenzetti, R.
Nardini, R.
Autorino, G.L.
Scicluna, M.T.; Pokaż więcej
Źródło:: In Journal of Equine Veterinary Science April 2016 39 Supplement:S54-S55

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 2.

Informacja:: Dostęp do tej pozycji wymaga zalogowania się.

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 3.

Tytuł:: Detection of Felis catus papillomavirus type-2 DNA and viral gene expression suggest active infection in feline oral squamous cell carcinoma.
Autorzy:: Altamura G; Department of Veterinary Medicine and Animal Productions, University of Naples Federico II, Naples, Italy.
Cardeti G; Istituto Zooprofilattico Sperimentale del Lazio e della Toscana 'M. Aleandri', Rome, Italy.
Cersini A; Istituto Zooprofilattico Sperimentale del Lazio e della Toscana 'M. Aleandri', Rome, Italy.
Eleni C; Istituto Zooprofilattico Sperimentale del Lazio e della Toscana 'M. Aleandri', Rome, Italy.
Cocumelli C; Istituto Zooprofilattico Sperimentale del Lazio e della Toscana 'M. Aleandri', Rome, Italy.
Bartolomé Del Pino LE; Istituto Zooprofilattico Sperimentale del Lazio e della Toscana 'M. Aleandri', Rome, Italy.
Razzuoli E; Istituto Zooprofilattico Sperimentale del Piemonte, Liguria e Valle d'Aosta, National Reference Center of Veterinary and Comparative Oncology (CEROVEC), Genoa, Italy.
Martano M; Department of Veterinary Medicine and Animal Productions, University of Naples Federico II, Naples, Italy.
Maiolino P; Department of Veterinary Medicine and Animal Productions, University of Naples Federico II, Naples, Italy.
Borzacchiello G; Department of Veterinary Medicine and Animal Productions, University of Naples Federico II, Naples, Italy.; Pokaż więcej
Źródło:: Veterinary and comparative oncology [Vet Comp Oncol] 2020 Dec; Vol. 18 (4), pp. 494-501. Date of Electronic Publication: 2020 Feb 03.
Typ publikacji:: Journal Article
MeSH Terms:: Cat Diseases/*genetics
Cat Diseases/*virology
Mouth Neoplasms/*veterinary
Papillomaviridae/*genetics
Papillomavirus Infections/*genetics
Squamous Cell Carcinoma of Head and Neck/*veterinary
Animals ; Cat Diseases/pathology ; Cats ; DNA, Viral ; Mouth Neoplasms/genetics ; Mouth Neoplasms/pathology ; Mouth Neoplasms/virology ; RNA, Messenger ; Real-Time Polymerase Chain Reaction/veterinary ; Squamous Cell Carcinoma of Head and Neck/genetics ; Squamous Cell Carcinoma of Head and Neck/pathology ; Squamous Cell Carcinoma of Head and Neck/virology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Antibiotics impair immune checkpoint inhibitor effectiveness in Hispanic patients with non-small cell lung cancer (AB-CLICaP).
Autorzy:: Ruiz-Patiño A; Foundation for Clinical and Applied Cancer Research (FICMAC), Bogotá, Colombia.; Molecular Oncology and Biology Systems Research Group (FOX-G), Universidad el Bosque, Bogotá, Colombia.
Barrón F; Thoracic Oncology Unit, Instituto Nacional de Cancerología, México City, Mexico.
Cardona AF; Foundation for Clinical and Applied Cancer Research (FICMAC), Bogotá, Colombia.; Molecular Oncology and Biology Systems Research Group (FOX-G), Universidad el Bosque, Bogotá, Colombia.; Clinical and Translational Oncology Group, Clínica del Country, Bogotá, Colombia.
Corrales L; Medical Oncology Department, Hospital San Juan de Dios, San José, Costa Rica.; Thoracic Oncology Department, Centro de Investigación y Manejo del Cáncer - CIMCA, San José, Costa Rica.
Mas L; Oncology Department, Instituto Nacional de Enfermedades Neoplásicas - IneN, Lima, Peru.
Martín C; Medical Oncology Department, Thoracic Oncology Section, Instituto Fleming, Buenos Aires, Argentina.
Zatarain-Barrón ZL; Thoracic Oncology Unit, Instituto Nacional de Cancerología, México City, Mexico.
Recondo G; Medical Oncology Department, Center for Medical Education and Clinical Research (CEMIC), Buenos Aires, Argentina.
Ricaurte L; Molecular Oncology and Biology Systems Research Group (FOX-G), Universidad el Bosque, Bogotá, Colombia.
Rojas L; Foundation for Clinical and Applied Cancer Research (FICMAC), Bogotá, Colombia.; Molecular Oncology and Biology Systems Research Group (FOX-G), Universidad el Bosque, Bogotá, Colombia.; Clinical and Translational Oncology Group, Clínica del Country, Bogotá, Colombia.; Clinical Oncology Department, Clínica Colsanitas, Bogotá, Colombia.
Archila P; Foundation for Clinical and Applied Cancer Research (FICMAC), Bogotá, Colombia.
Rodríguez J; Foundation for Clinical and Applied Cancer Research (FICMAC), Bogotá, Colombia.
Sotelo C; Foundation for Clinical and Applied Cancer Research (FICMAC), Bogotá, Colombia.
Viola L; Thoracic Oncology Unit, Fundación Neumológica Colombiana- FNC, Bogotá, Colombia.
Vargas C; Foundation for Clinical and Applied Cancer Research (FICMAC), Bogotá, Colombia.; Molecular Oncology and Biology Systems Research Group (FOX-G), Universidad el Bosque, Bogotá, Colombia.; Clinical and Translational Oncology Group, Clínica del Country, Bogotá, Colombia.
Carranza H; Foundation for Clinical and Applied Cancer Research (FICMAC), Bogotá, Colombia.; Molecular Oncology and Biology Systems Research Group (FOX-G), Universidad el Bosque, Bogotá, Colombia.; Clinical and Translational Oncology Group, Clínica del Country, Bogotá, Colombia.
Otero J; Foundation for Clinical and Applied Cancer Research (FICMAC), Bogotá, Colombia.; Molecular Oncology and Biology Systems Research Group (FOX-G), Universidad el Bosque, Bogotá, Colombia.
Pino LE; Oncology Department, Institute of Oncology - ICAL, Fundación Santa Fe de Bogotá, Bogotá, Colombia.
Rolfo C; Thoracic Oncology Unit, Marlene and Stewart Comprehensive Cancer Center, University of Maryland, Baltimore, Maryland, USA.
Rosell R; Institut d'Investigació en Ciències Germans Trias i Pujol, Badalona, Spain.; Institut Català d'Oncologia, Hospital Germans Trias i Pujol, Badalona, Spain.
Arrieta O; Thoracic Oncology Unit, Instituto Nacional de Cancerología, México City, Mexico.; Pokaż więcej
Corporate Authors:: CLICaP
Źródło:: Thoracic cancer [Thorac Cancer] 2020 Sep; Vol. 11 (9), pp. 2552-2560. Date of Electronic Publication: 2020 Jul 24.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Anti-Bacterial Agents/*adverse effects
Carcinoma, Non-Small-Cell Lung/*drug therapy
Immune Checkpoint Inhibitors/*therapeutic use
Immunotherapy/*adverse effects
Lung Neoplasms/*drug therapy
Carcinoma, Non-Small-Cell Lung/pathology ; Female ; Humans ; Immune Checkpoint Inhibitors/pharmacology ; Lung Neoplasms/pathology ; Male ; Retrospective Studies

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Immunotherapy at any line of treatment improves survival in patients with advanced metastatic non-small cell lung cancer (NSCLC) compared with chemotherapy (Quijote-CLICaP).
Autorzy:: Ruiz-Patiño A; Foundation for Clinical and Applied Cancer Research (FICMAC), Bogotá, Colombia.; Molecular Oncology and Biology Systems Research Group (FOX-G), Universidad el Bosque, Bogotá, Colombia.
Arrieta O; Thoracic Oncology Unit, Instituto Nacional de Cancerología (INCan), México City, Mexico.
Cardona AF; Foundation for Clinical and Applied Cancer Research (FICMAC), Bogotá, Colombia.; Molecular Oncology and Biology Systems Research Group (FOX-G), Universidad el Bosque, Bogotá, Colombia.; Clinical and Translational Oncology Group, Institute of Oncology, Clínica del Country, Bogotá, Colombia.
Martín C; Medical Oncology Department, Thoracic Oncology Section, Instituto Fleming, Buenos Aires, Argentina.
Raez LE; Thoracic Oncology Program, Memorial Cancer Institute/Florida International University, Miami, Florida, USA.
Zatarain-Barrón ZL; Thoracic Oncology Unit, Instituto Nacional de Cancerología (INCan), México City, Mexico.
Barrón F; Thoracic Oncology Unit, Instituto Nacional de Cancerología (INCan), México City, Mexico.
Ricaurte L; Foundation for Clinical and Applied Cancer Research (FICMAC), Bogotá, Colombia.
Bravo-Garzón MA; Hematology and Oncology Department, Hospital Militar Central, Bogotá, Colombia.
Mas L; Oncology Department, Instituto Nacional de Enfermedades Neoplásicas - IneN, Lima, Peru.
Corrales L; Medical Oncology Department, Hospital San Juan de Dios, San José, Costa Rica.
Rojas L; Clinical and Translational Oncology Group, Institute of Oncology, Clínica del Country, Bogotá, Colombia.; Oncology Department, Clínica Colsanitas, Bogotá, Colombia.
Lupinacci L; Thoracic Oncology Unit, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
Perazzo F; Section of Oncology, CEMIC Buenos Aires, Buenos Aires, Argentina.
Bas C; Oncology Department, Hospital Alemán, Buenos Aires, Argentina.
Carranza O; Oncology Department, Hospital Privado de la Comunidad de Mar del Plata, Mar del Plata, Argentina.
Puparelli C; Medical Oncology Department, Thoracic Oncology Section, Instituto Fleming, Buenos Aires, Argentina.
Rizzo M; Oncology Department, Hospital Austral de Buenos Aires, Buenos Aires, Argentina.
Ruiz R; Hematology and Oncology Department, Hospital Militar Central, Bogotá, Colombia.
Rolfo C; Thoracic Oncology Unit, Marlene and Stewart Comprehensive Cancer Center, University of Maryland, Baltimore, MD, USA.
Archila P; Foundation for Clinical and Applied Cancer Research (FICMAC), Bogotá, Colombia.
Rodríguez J; Foundation for Clinical and Applied Cancer Research (FICMAC), Bogotá, Colombia.
Sotelo C; Foundation for Clinical and Applied Cancer Research (FICMAC), Bogotá, Colombia.
Vargas C; Foundation for Clinical and Applied Cancer Research (FICMAC), Bogotá, Colombia.; Molecular Oncology and Biology Systems Research Group (FOX-G), Universidad el Bosque, Bogotá, Colombia.; Clinical and Translational Oncology Group, Institute of Oncology, Clínica del Country, Bogotá, Colombia.
Carranza H; Foundation for Clinical and Applied Cancer Research (FICMAC), Bogotá, Colombia.; Molecular Oncology and Biology Systems Research Group (FOX-G), Universidad el Bosque, Bogotá, Colombia.; Clinical and Translational Oncology Group, Institute of Oncology, Clínica del Country, Bogotá, Colombia.
Otero J; Foundation for Clinical and Applied Cancer Research (FICMAC), Bogotá, Colombia.; Molecular Oncology and Biology Systems Research Group (FOX-G), Universidad el Bosque, Bogotá, Colombia.; Clinical and Translational Oncology Group, Institute of Oncology, Clínica del Country, Bogotá, Colombia.
Pino LE; Oncology Department, Institute of Oncology - ICAL, Fundación Santa Fe de Bogotá, Bogotá, Colombia.
Ortíz C; Clinical and Translational Oncology Group, Institute of Oncology, Clínica del Country, Bogotá, Colombia.
Laguado P; Clinical and Translational Oncology Group, Institute of Oncology, Clínica del Country, Bogotá, Colombia.
Rosell R; Coyote Research Group, Pangaea Oncology, Laboratory of Molecular Biology, Quiron-Dexeus University Institute, Barcelona, Spain.; Institut d'Investigació en Ciències Germans Trias i Pujol, Badalona, Spain.; Institut Català d'Oncologia, Hospital Germans Trias i Pujol, Badalona, Spain.; Pokaż więcej
Corporate Authors:: CLICaP
Źródło:: Thoracic cancer [Thorac Cancer] 2020 Feb; Vol. 11 (2), pp. 353-361. Date of Electronic Publication: 2019 Dec 12.
Typ publikacji:: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Antineoplastic Agents, Immunological/*therapeutic use
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Carcinoma, Non-Small-Cell Lung/*mortality
Carcinoma, Squamous Cell/*mortality
Immunotherapy/*mortality
Lung Neoplasms/*mortality
Adult ; Aged ; Aged, 80 and over ; Carcinoma, Non-Small-Cell Lung/drug therapy ; Carcinoma, Non-Small-Cell Lung/immunology ; Carcinoma, Non-Small-Cell Lung/pathology ; Carcinoma, Squamous Cell/drug therapy ; Carcinoma, Squamous Cell/immunology ; Carcinoma, Squamous Cell/pathology ; Female ; Follow-Up Studies ; Humans ; Lung Neoplasms/drug therapy ; Lung Neoplasms/immunology ; Lung Neoplasms/pathology ; Male ; Middle Aged ; Prognosis ; Retrospective Studies ; Survival Rate

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Systemic management of malignant meningiomas: A comparative survival and molecular marker analysis between Octreotide in combination with Everolimus and Sunitinib.
Autorzy:: Cardona AF; Brain Tumor Section, Clinical and Translational Oncology Group, Clínica del Country, Bogotá, Colombia.; Foundation for Clinical and Applied Cancer Research-FICMAC, Bogotá, Colombia.; Molecular Oncology and Biology Systems Group (G-FOX), Universidad El Bosque, Bogotá, Colombia.
Ruiz-Patiño A; Foundation for Clinical and Applied Cancer Research-FICMAC, Bogotá, Colombia.
Zatarain-Barrón ZL; Laboratory of Experimental Oncology, Instituto Nacional de Cancerología (INCaN), México City, México.
Hakim F; Neurosurgery Department, Fundación Santa Fe de Bogotá, Bogotá, Colombia.; Neuroscience Department, Universidad El Bosque, Bogotá, Colombia.
Jiménez E; Neurosurgery Department, Fundación Santa Fe de Bogotá, Bogotá, Colombia.; Neuroscience Department, Universidad El Bosque, Bogotá, Colombia.
Mejía JA; Neurosurgery Department, Fundación Santa Fe de Bogotá, Bogotá, Colombia.; Neuroscience Department, Universidad El Bosque, Bogotá, Colombia.
Ramón JF; Neurosurgery Department, Fundación Santa Fe de Bogotá, Bogotá, Colombia.; Neuroscience Department, Universidad El Bosque, Bogotá, Colombia.
Useche N; Neuroscience Department, Universidad El Bosque, Bogotá, Colombia.; Neuroradiology Section, Radiology Department, Fundación Santa Fe de Bogotá, Bogotá, Colombia.
Bermúdez S; Neuroscience Department, Universidad El Bosque, Bogotá, Colombia.; Neuroradiology Section, Radiology Department, Fundación Santa Fe de Bogotá, Bogotá, Colombia.
Pineda D; Brain Tumor Section, Clinical and Translational Oncology Group, Clínica del Country, Bogotá, Colombia.; Neuroradiology Section, Clínica del Country, Bogotá, Colombia.
Cifuentes H; Neurosurgery Department, Clínica del Country, Bogotá, Colombia.
Rojas L; Brain Tumor Section, Clinical and Translational Oncology Group, Clínica del Country, Bogotá, Colombia.; Foundation for Clinical and Applied Cancer Research-FICMAC, Bogotá, Colombia.; Clinical Oncology Department, Clínica Colsanitas, Bogotá, Colombia.
Ricaurte L; Foundation for Clinical and Applied Cancer Research-FICMAC, Bogotá, Colombia.
Pino LE; Clinical Oncology Group, Fundación Santa Fe de Bogotá, Bogotá, Colombia.
Balaña C; Neuro-Oncology Section, Oncology Department, Hospital Germans Trias I Pujol, Catalan Institute of Oncology-ICO, Barcelona, Spain.
Arrieta O; Laboratory of Experimental Oncology, Instituto Nacional de Cancerología (INCaN), México City, México.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2019 Jun 20; Vol. 14 (6), pp. e0217340. Date of Electronic Publication: 2019 Jun 20 (Print Publication: 2019).
Typ publikacji:: Clinical Trial; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Meningeal Neoplasms*/blood
Meningeal Neoplasms*/drug therapy
Meningeal Neoplasms*/mortality
Meningioma*/blood
Meningioma*/drug therapy
Meningioma*/mortality
Antineoplastic Combined Chemotherapy Protocols/*administration & dosage
Biomarkers, Tumor/*blood
Gene Expression Regulation, Neoplastic/*drug effects
Neoplasm Proteins/*blood
Receptor, Platelet-Derived Growth Factor beta/*blood
Vascular Endothelial Growth Factor Receptor-2/*blood
Adult ; Aged ; Aged, 80 and over ; Disease-Free Survival ; Everolimus/administration & dosage ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Octreotide/administration & dosage ; Retrospective Studies ; Sunitinib/administration & dosage ; Survival Rate

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Convergence of developmental mutants into a single tomato model system: 'Micro-Tom' as an effective toolkit for plant development research.
Autorzy:: Carvalho RF; Laboratory of Hormonal Control of Plant Development, Department of Biological Sciences (LCB), Escola Superior de Agricultura 'Luiz de Queiroz' (ESALQ), Universidade de São Paulo (USP) - Av. Pádua Dias, 11, CP 09, CEP 13418-900 Piracicaba - SP, Brazil.
Campos ML; Laboratory of Hormonal Control of Plant Development, Department of Biological Sciences (LCB), Escola Superior de Agricultura 'Luiz de Queiroz' (ESALQ), Universidade de São Paulo (USP) - Av. Pádua Dias, 11, CP 09, CEP 13418-900 Piracicaba - SP, Brazil.
Pino LE; Laboratory of Hormonal Control of Plant Development, Department of Biological Sciences (LCB), Escola Superior de Agricultura 'Luiz de Queiroz' (ESALQ), Universidade de São Paulo (USP) - Av. Pádua Dias, 11, CP 09, CEP 13418-900 Piracicaba - SP, Brazil.; Center for Nuclear Energy in Agriculture (CENA), USP, Av. Centenário, 303, CEP 13400-970 Piracicaba, SP, Brazil.
Crestana SL; Laboratory of Hormonal Control of Plant Development, Department of Biological Sciences (LCB), Escola Superior de Agricultura 'Luiz de Queiroz' (ESALQ), Universidade de São Paulo (USP) - Av. Pádua Dias, 11, CP 09, CEP 13418-900 Piracicaba - SP, Brazil.
Zsögön A; Laboratory of Hormonal Control of Plant Development, Department of Biological Sciences (LCB), Escola Superior de Agricultura 'Luiz de Queiroz' (ESALQ), Universidade de São Paulo (USP) - Av. Pádua Dias, 11, CP 09, CEP 13418-900 Piracicaba - SP, Brazil.
Lima JE; Laboratory of Hormonal Control of Plant Development, Department of Biological Sciences (LCB), Escola Superior de Agricultura 'Luiz de Queiroz' (ESALQ), Universidade de São Paulo (USP) - Av. Pádua Dias, 11, CP 09, CEP 13418-900 Piracicaba - SP, Brazil.; Center for Nuclear Energy in Agriculture (CENA), USP, Av. Centenário, 303, CEP 13400-970 Piracicaba, SP, Brazil.
Benedito VA; Genetics and Developmental Biology Program, Plant and Soil Sciences Division, West Virginia University, 2090 Agricultural Sciences Building, Morgantown, WV 26506, USA.
Peres LE; Laboratory of Hormonal Control of Plant Development, Department of Biological Sciences (LCB), Escola Superior de Agricultura 'Luiz de Queiroz' (ESALQ), Universidade de São Paulo (USP) - Av. Pádua Dias, 11, CP 09, CEP 13418-900 Piracicaba - SP, Brazil.; Pokaż więcej
Źródło:: Plant methods [Plant Methods] 2011 Jun 29; Vol. 7 (1), pp. 18. Date of Electronic Publication: 2011 Jun 29.
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: The Rg1 allele as a valuable tool for genetic transformation of the tomato 'Micro-Tom' model system.
Autorzy:: Pino LE; Department of Biological Sciences (LCB), Escola Superior de Agricultura 'Luiz de Queiroz' (ESALQ), Universidade de São Paulo (USP), Av, Pádua Dias, 11, CP 09, Piracicaba, SP, 13418-900, Brazil. .
Lombardi-Crestana S
Azevedo MS
Scotton DC
Borgo L
Quecini V
Figueira A
Peres LE; Pokaż więcej
Źródło:: Plant methods [Plant Methods] 2010 Oct 07; Vol. 6, pp. 23. Date of Electronic Publication: 2010 Oct 07.
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Pino LE"" wg kryterium: Autor

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język